QQ客服 官方微博 反馈留言

	Inhibition of P53/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1
	Huang, Wenlin; Jia, Ye; Wu, Hao; Jiang, Ziping; Wu, Junduo; Liang, Wenzhao; Tian, Yueli; Ma, Fuzhe
刊名	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
	2019
卷号	23期号:5
关键词	aorta diabetes endothelial dysfunction miR-34a P53
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3535112
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Huang, Wenlin,Jia, Ye,Wu, Hao,et al. Inhibition of P53/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1[J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2019,23(5).
APA	Huang, Wenlin.,Jia, Ye.,Wu, Hao.,Jiang, Ziping.,Wu, Junduo.,...&Ma, Fuzhe.(2019).Inhibition of P53/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,23(5).
MLA	Huang, Wenlin,et al."Inhibition of P53/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1".JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 23.5(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。